AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

The UK-based firm, which emerged from Google DeepMind in 2021, has not disclosed the target condition or a specific timeline for the trial’s commencement.

MSFT Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

News Business Google merges DeepMind, Brain research units as AI race intensifies April 20, 2023 Updated Thu., April 20, 2023 at 4 p.m. (New York Times) X Email Reddit ...

Isomorphic Labs is nearing human clinical trials for drugs developed using AI. Isomorphic helps pharma partners with their drug development programs while also working on its own internal drug ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...

The statements are contained in a 145-page paper outlining Google DeepMind's approach to AI safety as it attempts to build advanced systems that may one day surpass human intelligence.

AI that is as powerful as the human brain could arrive within the next few years, according to the boss of Google-owned AI lab DeepMind. The Wall Street Journal reported the news.

Google DeepMind says in a new research paper that human-level AI could plausibly arrive by 2030 and "permanently destroy humanity." ...